Hem › Follikulärt lymfom › Maryland › Baltimore
Kliniska studier för Follikulärt lymfom i Baltimore, MD
4 studier för Follikulärt lymfom söker deltagare vid platser i och runt Baltimore (inom ca 30 miles). Öppna en studie för att se vem som kan delta och hur du kontaktar studieteamet.
Officiell studietext (engelska)
Rekryterar du till en studie? Visa den högst upp på sidan – $99 i 30 dagar →
A Study of Surovatamig (AZD0486) Plus Rituximab in Previously Untreated Follicular Lymphoma Patients
RekryterarFas 3
- Research Site, Baltimore
A Study to Compare the Efficacy and Safety of Golcadomide in Combination With Rituximab (Golca + R) vs Investigator's Choice in Participants With Relapsed/Refractory Follicular Lymphoma Who Have Received at Least 1 Prior Line of Systemic Therapy (GOLSEEK-4)
RekryterarFas 3
- Local Institution - 0023, Baltimore
- Greater Baltimore Medical Center, Towson · 8 mi bort
AS-1763 in Patients With Previously Treated CLL/SLL or Non-Hodgkin Lymphoma
RekryterarFas 1
- University of Maryland Medical Center - Greenebaum Comprehensive Cancer Center, Baltimore
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RekryterarObservationsstudie
- Massive Bio SYNERGY-AI site, Baltimore
- Massive Bio SYNERGY-AI site, Towson · 8 mi bort
Follikulärt lymfom-studier i andra städer
- New York City, NY24 studier
- Milwaukee, WI19 studier
- Nashville, TN18 studier
- Houston, TX18 studier
- Boston, MA17 studier
- Baldwin Park, CA16 studier
- Seattle, WA15 studier
- Durham, NC15 studier
- Columbus, OH13 studier
- Salt Lake City, UT13 studier
- Chicago, IL12 studier
- San Antonio, TX12 studier
Andra studier i Baltimore
- Icke-småcellig lungcancer60 studier
- Bröstcancer47 studier
- Prostatacancer43 studier
- Lungcancer40 studier
- Cancer (alla typer)37 studier
- Kolorektal cancer31 studier
- Bukspottkörtelcancer31 studier
- Metastaserande cancer28 studier
- Övervikt25 studier
- Hjärtsvikt24 studier
- Blåscancer24 studier
- Stroke22 studier
Från ClinicalTrials.gov, data hämtad 5 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.